LOGIN  |  REGISTER
Astria Therapeutics

Varex Imaging Announces Non-intrusive Cargo Inspection Systems Orders Valued at $17 Million

July 14, 2025 | Last Trade: US$7.93 0.24 -2.94

SALT LAKE CITY / Jul 14, 2025 / Business Wire / Varex Imaging Corporation (Nasdaq: VREX) today announced that it has received orders for its high-energy non-intrusive cargo and vehicle inspection systems valued at approximately $17 million USD from international customers. The systems will be placed at strategic locations securing sea and land ports.

Varex Imaging CEO, Sunny Sanyal, stated “We are pleased to announce additional orders this fiscal year for our Cargo Systems business, totaling over $55 million of orders year-to-date and believe this is a testament to our strong reputation in high energy Linear Accelerator based imaging and our ability to integrate this technology into our own Varex systems. We are pleased to support the efforts of our customers globally to promote safe and secure ports and borders.”

For more information about Varex’s non-intrusive cargo inspection systems, please contact your Varex representative or visit our website at https://www.vareximaging.com/security-solutions/.

About Varex

Varex Imaging Corporation is a leading innovator, designer, and manufacturer of X-ray imaging components, which include X-ray tubes, digital detectors, and other image processing solutions that are key components of X-ray imaging systems, as well as X-ray imaging systems for industrial applications. With a 70+ year history of successful innovation, Varex’s products are used in medical imaging as well as in industrial and security imaging applications. Global OEM manufacturers incorporate the company’s X-ray sources, digital detectors, connecting devices, and imaging software in their systems to detect, diagnose, protect, and inspect. Headquartered in Salt Lake City, Utah, Varex employs approximately 2,300 people located in North America, Europe, and Asia. For more information visit vareximaging.com.

Forward Looking Statements

This news release contains “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements concerning interest in and adoption and performance of our products and systems; our technology and reputation enabling us to win business; our ability to integrate high energy linear accelerator technology into our own systems; the impact of our system on the safety and security of infrastructures; and any statements using the terms “believe,” “expect,” “could,” “may,” “promote,” and “possible” or similar statements are forward-looking statements that involve risks and uncertainties that could cause our actual results and the outcome and timing of certain events to differ materially from those projected or management’s current expectations. Any forward-looking statement made by us in this news release speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. Varex assumes no obligation to update or revise the forward-looking statements in this release because of new information, future events, or otherwise.

C4 Therapeutics

Stock Quote

Featured Stock

Amneal Pharmaceuticals

Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...

CLICK TO LEARN MORE

Featured Stock

Immix Biopharma

Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page